Literature DB >> 23868474

The equipoise of perioperative anticoagulation management: a Canadian cross-sectional survey.

Leslie Skeith1, Alejandro Lazo-Langner, Michael J Kovacs.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 23868474     DOI： 10.1007/s11239-013-0960-6

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  9 in total

Review 1.  How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch.

Authors:  Sam Schulman; Mark A Crowther
Journal:  Blood       Date:  2012-02-01       Impact factor: 22.113

2.  Pro: "Bridging anticoagulation is needed during warfarin interruption in patients who require elective surgery".

Authors:  Alex C Spyropoulos
Journal:  Thromb Haemost       Date:  2012-06-12       Impact factor: 5.249

3.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Oral rivaroxaban for symptomatic venous thromboembolism.

Authors:  Rupert Bauersachs; Scott D Berkowitz; Benjamin Brenner; Harry R Buller; Hervé Decousus; Alex S Gallus; Anthonie W Lensing; Frank Misselwitz; Martin H Prins; Gary E Raskob; Annelise Segers; Peter Verhamme; Phil Wells; Giancarlo Agnelli; Henri Bounameaux; Alexander Cohen; Bruce L Davidson; Franco Piovella; Sebastian Schellong
Journal:  N Engl J Med       Date:  2010-12-03       Impact factor: 91.245

5.  Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.

Authors:  Amir K Jaffer; Mudassar Ahmed; Daniel J Brotman; Lee Bragg; Niranjan Seshadri; Mohammed A Qadeer; Allan Klein
Journal:  J Thromb Thrombolysis       Date:  2005-08       Impact factor: 2.300

Review 6.  How I treat anticoagulated patients undergoing an elective procedure or surgery.

Authors:  Alex C Spyropoulos; James D Douketis
Journal:  Blood       Date:  2012-08-28       Impact factor: 22.113

Review 7.  Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.

Authors:  Deborah Siegal; Jovana Yudin; Scott Kaatz; James D Douketis; Wendy Lim; Alex C Spyropoulos
Journal:  Circulation       Date:  2012-08-21       Impact factor: 29.690

8.  Conservative perioperative anticoagulation management in patients with chronic venous thromboembolic disease: a cohort study.

Authors:  L Skeith; J Taylor; A Lazo-Langner; M J Kovacs
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

9.  Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.

Authors:  M J Kovacs; C Kearon; M Rodger; D R Anderson; A G G Turpie; S M Bates; L Desjardins; J Douketis; S R Kahn; S Solymoss; P S Wells
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690
  9 in total
  1 in total

1.  A physician survey of perioperative neuraxial anesthesia management in patients on a direct oral anticoagulant.

Authors:  James D Douketis; Summer Syed; Na Li; Samer Narouze; Mansoor Radwi; Joanne Duncan; Sam Schulman; Alex C Spyropoulos
Journal:  Res Pract Thromb Haemost       Date:  2020-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.